Bio Integrates 2023 Track 2
PLANNING
Everything else that is important to success that’s not the science!
Fireside Chat
Fireside Chat
Camilla Easter | Chief Executive Officer | Oxford Medical Products
Vineeta Tripathi | Chief Executive Officer, Chief Scientific Officer | Vitarka Therapeutics
Lydia Mapstone | Chief Executive Officer and Co-founder | BoobyBiome
Interviewed by
Martino Picardo | Chairman | Discovery Park
Walking the antibody catwalk
Therapeutic antibody design and engineering – is this modality still relevant – is C> taking over, or is there a resurgence of small molecules?
FACILITATED BY
Alan Boyd | CEO & Founder | Boyds
PANELLISTS
Marc Wilkinson | Partner, European and UK Patent Attorney | J A Kemp LLP
Jolyon Martin | Co-Founder and Head of Business Development | PetMedix
Adrian Kinkaid | Chief Executive Officer | Fusion Antibodies
Fiona Dempsey | Director of Scientific Operations | Medannex
Carolyn Flanigan | Director of Operations | Absolute Antibody
Growing in a time of drought
Getting investment to grow your business; fundraising in a tough environment
FACILITATED BY
Jason Mellad | Chief Executive Officer | Start Codon
PANELLISTS
Tessa Pugh | Chief Executive Officer & Co-founder | PharmaReview
Jenny Button | Chief Executive Officer | Emm
Tina Flatau | Chief Business Officer | Sixfold Bioscience
Jo Derbyshire | Director of Grants and Tenders | Inventya Group
Michal Barski | Chief Executive Officer | Reciprocal Space
Tick tock, tick tock …
Scaling up – I’ve got my investment, now how do I deliver the next milestones quickly? Including team, manufacturing, capacity & making it happen.
FACILITATED BY
Jenny Laird | Vice President, Search & Evaluation Pain & Neurodegeneration | Eli Lilly and Company
PANELLISTS
John von Benecke | Chief Executive Officer | Locate Bio
Nigel Brooks | Coach & Advisor | Lean Life Science
Will Brooks | Investment Director | Downing
Nick Smith | Regional Operationas Manager | Scitech
Craig Fox | Operating Partner Life Sciences | Oxford Science Enterprises
Managing your partners
Managing your CDMO and CRO partners to get the slots you need when you need them – does a small entity have any leverage?
FACILITATED BY
Jo Craig | Senior Vice President CMC | NeRRe Therapeutics
PANELLISTS
Chris Davison | Chief Executive Officer | Custom Pharma Services
Roel de Nobel | General Manager & SVP Business Unit Solids | Aenova Group
Rabia Khan | Founder & Chief Executive Officer | Serna Bio
Andy Clarke | Managing Director and Country Manager | YSDS